Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McGill University

$135,000.00

Identification and fuctional characterization of novel and known proteins involved in Parkinson's disease; exome sequencing and functional genetics approach

FY 2012-13

Summary
More than 100,000 Canadians have Parkinson's disease, a chronic, progressive and devastating disorder, which creates a huge burden on the individual, his family, and the entire society. This burden is physical, social, psychological and financial, and as the age of the population increases, more and more individuals are expected to develop Parkinson's disease. In this proposed project, we will study the French-Canadian population for genetic alterations that either increase or decrease the risk for Parkinson's disease. We will use advanced genetic methods to identify these genetic changes, such as exome sequencing, and will follow up by studying the biology of these changes in cellular models of Parkinson's disease. In addition, we will study already known genetic changes that increase the risk for PD in the French-Canadian population, such as mutations in a gene called GBA, that are found in more than ten percent of French Canadians who have Parkinson's disease. The proposed study will take place in one of the world's best labs that study genetics of neurological diseases, led by Dr. Guy Rouleau, the director of the Montreal Neurological Institute. This lab identified more than 20 genes that are associated to different neurological conditions. Dr. Ziv Gan-Or performed his PhD on the genetics of Parkinson's disease, and is experienced with studying a founder population, as well as with the GBA gene, which was his main target of investigation of his PhD thesis. We are expecting that this proposed research will identify new genetic elements that cause Parkinson's disease, or affect the chances to get this disease. Identifying these elements will allow us to study the biology of Parkinson's disease, start developing new treatments, but may also have an immediate effect, as it will allow us to identify individuals that tend to have Parkinson's disease, and diagnose the disease in earlier stages, which may affect the efficiency of the treatment.
Program
CIHR Fellowship
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
281830
Name
Gan-Or Ziv
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Identification and fuctional characterization of novel and known proteins involved in Parkinson's disease; exome sequencing and functional genetics approach
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Exome Sequencing; Founder Population; Genetics; Parkinson'S Diseae
Abstract
More than 100,000 Canadians have Parkinson's disease, a chronic, progressive and devastating disorder, which creates a huge burden on the individual, his family, and the entire society. This burden is physical, social, psychological and financial, and as the age of the population increases, more and more individuals are expected to develop Parkinson's disease. In this proposed project, we will study the French-Canadian population for genetic alterations that either increase or decrease the risk for Parkinson's disease. We will use advanced genetic methods to identify these genetic changes, such as exome sequencing, and will follow up by studying the biology of these changes in cellular models of Parkinson's disease. In addition, we will study already known genetic changes that increase the risk for PD in the French-Canadian population, such as mutations in a gene called GBA, that are found in more than ten percent of French Canadians who have Parkinson's disease. The proposed study will take place in one of the world's best labs that study genetics of neurological diseases, led by Dr. Guy Rouleau, the director of the Montreal Neurological Institute. This lab identified more than 20 genes that are associated to different neurological conditions. Dr. Ziv Gan-Or performed his PhD on the genetics of Parkinson's disease, and is experienced with studying a founder population, as well as with the GBA gene, which was his main target of investigation of his PhD thesis. We are expecting that this proposed research will identify new genetic elements that cause Parkinson's disease, or affect the chances to get this disease. Identifying these elements will allow us to study the biology of Parkinson's disease, start developing new treatments, but may also have an immediate effect, as it will allow us to identify individuals that tend to have Parkinson's disease, and diagnose the disease in earlier stages, which may affect the efficiency of the treatment.
Competitiondate
201302
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gan-Or, Ziv
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~